Best-in-class, Fraud.Net offers an AI-driven platform that empowers enterprises to combat fraud, streamline compliance, and manage risk at scale—all in real-time. Our cutting-edge technology detects threats before they impact your operations, providing highly accurate risk scoring that adapts to evolving fraud patterns through billions of analyzed transactions.
Our unified platform delivers complete protection through three proprietary capabilities: instant AI-powered risk scoring, continuous monitoring for proactive threat detection, and precision fraud prevention across payment types and channels. Additionally, Fraud.Net centralizes your fraud and risk management strategy while delivering advanced analytics that provide unmatched visibility and significantly reduce false positives and operational inefficiencies.
Trusted by payments companies, financial services, fintech, and commerce leaders worldwide, Fraud.Net tracks over a billion identities and protects against 600+ fraud methodologies, helping clients reduce fraud by 80% and false positives by 97%. Our no-code/low-code architecture ensures customizable workflows that scale with your business, and our Data Hub of dozens of 3rd party data integrations and Global Anti-Fraud Network ensures unparalleled accuracy.
Fraud is complex, but prevention shouldn't be. With FraudNet, you can build resilience today for tomorrow's opportunities. Request a demo today.
Learn more
SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more
Claude Mythos 5.1
Claude Mythos 5.1 signifies the latest evolution in the Mythos series of models developed by Anthropic, specifically designed for advanced applications across fields such as cybersecurity, biology, scientific research, programming, and extensive knowledge-intensive tasks. Although it is built on the same core architecture as Claude Fable 5.1, it stands out due to its distinct safety protocols: while Fable 5.1 is broadly available, Mythos 5.1 is restricted to select trusted access initiatives that incorporate specialized safeguards for cybersecurity and life sciences. This model sets a new standard for performance in autonomous coding and exhibits unmatched cyber capabilities compared to all previous Anthropic models. In the scientific research domain, Mythos 5.1 adeptly manages specialized tools and complex workflows related to molecular design, computational biology, and other technical disciplines. During Anthropic's evaluation, it successfully designed high-affinity protein binders for various targets, achieving its highest hit rate to date. Furthermore, it excelled in optimizing seven distinct open-source deep learning models that focus on protein and genomics. By advancing the limits of what can be accomplished, Mythos 5.1 is poised to play a pivotal role in shaping future research and development projects, ultimately influencing a wide array of scientific inquiries and technological innovations. Its capabilities suggest a transformative impact on how complex biological and computational problems are approached in the coming years.
Learn more
Evo 2
Evo 2 is an advanced genomic foundation model that excels in predicting and creating tasks associated with DNA, RNA, and proteins. Utilizing a sophisticated deep learning architecture, it models biological sequences with precision down to single-nucleotide accuracy, demonstrating remarkable scalability in both computational and memory resources as context length expands. The model has been trained on an impressive 40 billion parameters and can handle a context length of 1 megabase, analyzing an immense dataset of over 9 trillion nucleotides derived from diverse eukaryotic and prokaryotic genomes. This extensive training enables Evo 2 to perform zero-shot function predictions across a range of biological types, including DNA, RNA, and proteins, while also generating novel sequences that adhere to plausible genomic frameworks. Its robust capabilities have been highlighted in applications such as the design of efficient CRISPR systems and the identification of potentially disease-causing mutations in human genes. Additionally, Evo 2 is accessible to the public via Arc's GitHub repository and is integrated into the NVIDIA BioNeMo framework, which significantly enhances its availability to researchers and developers. This integration not only broadens the model's reach but also represents a pivotal advancement in the fields of genomic modeling and analysis, paving the way for future innovations in biotechnology.
Learn more
